Gene Transfer Trial for Cancer
Phase 1/2
110
about 11 years
18–72
1 site in MD
What this study is about
This trial is testing a new treatment that involves taking white blood cells from your body, modifying them in the lab with a special gene, and then returning them to you. The goal is to determine if this modified cell therapy is safe and can shrink tumors in people with certain types of cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Anti-KRAS G12V mTCR PBL
- 2.Take Aldesleukin
- 3.Take Cyclophosphamide
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
aldesleukin, cyclophosphamide (Alkylating chemotherapy; crosslinks DNA strands), fludarabine
infusion
Primary: Frequency and severity of treatment-related adverse events, Response rate
Oncology